FDA Approved: MESNA — Original Application (Ingenus Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved the original application for MESNA (Ingenus Pharmaceuticals, LLC) to reduce the risk of chemotherapy-related hemorrhagic cystitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhagic Cystitis

Drugs mentioned

• MESNA (MESNA)

Snippet

ORIG AP for MESNA (MESNA)